Taylor Vinters advised RQ Bio on the deal. RQ Bio emerges from stealth mode announcing its launch as a new UK-based biotechnology company following the completion...
RQ Bio’s $157 Million Licence With AstraZeneca
DIOSynVax’s $42 Million Deal With CEPI
Taylor Vinters advised DIOSynVax on the deal. DIOSynVax agreed for a $42m deal with CEPI, announced at the Global Pandemic Preparedness Summit in Oslo, Norway. The...